본문 바로가기
KERD
논문KCI 등재

The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry

김종진|이승훈|홍영준|안영근|정명호|김영조|심두선|조명찬|김현국
대한내과학회 (The Korean Association Of Internal Medicine)|2014.11|The Korean Journal of Internal Medicine|제29권 제6호|pp. 703-712|DOI http://dx.doi.org/10.3904/kjim.2014.29.6.703

2

조회

0

다운로드

7

인용

0

참고문헌

키워드

Acute myocardial infarctionPrognosisTherapeutics
주제분류내과학

초록

The Korea Acute Myocardial Infarction Registry (KAMIR) was the first nationwideregistry data collection designed to track outcomes of patients with acutemyocardial infarction (AMI). These studies ref lect the current therapeutic approachesand management for AMI in Korea. The results of KAMIR could helpclinicians to predict the prognosis of their patients and identify better diagnosticand treatment tools to improve the quality of care. The KAMIR score was proposedto be a predictor of the prognosis of AMI patients. Triple antiplatelet therapy,consisting of aspirin, clopidogrel and cilostazol, was effective at preventingmajor adverse clinical outcomes. Drug-eluting stents were effective and safe inAMI patients with no increased risk of stent thrombosis. Statin therapy was effectivein Korean AMI patients, including those with very low levels of low densitycholesterol. The present review summarizes the 10-year scientific achievements ofKAMIR from admission to outpatient care during long-term clinical follow-up.

Abstract

The Korea Acute Myocardial Infarction Registry (KAMIR) was the first nationwideregistry data collection designed to track outcomes of patients with acutemyocardial infarction (AMI). These studies ref lect the current therapeutic approachesand management for AMI in Korea. The results of KAMIR could helpclinicians to predict the prognosis of their patients and identify better diagnosticand treatment tools to improve the quality of care. The KAMIR score was proposedto be a predictor of the prognosis of AMI patients. Triple antiplatelet therapy,consisting of aspirin, clopidogrel and cilostazol, was effective at preventingmajor adverse clinical outcomes. Drug-eluting stents were effective and safe inAMI patients with no increased risk of stent thrombosis. Statin therapy was effectivein Korean AMI patients, including those with very low levels of low densitycholesterol. The present review summarizes the 10-year scientific achievements ofKAMIR from admission to outpatient care during long-term clinical follow-up.

참고문헌 (89)

  1. Kim HK, "A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction", Int J Cardiol, 145, pp.450~454 (2010)
  2. score), "Am J Cardiol", 2011, 965.e1~971.e1
  3. Kim KH, "The CHADSVASc score can be used to stratify the prognosis of acute myocardial infarction patients irrespective of presence of atrial fibrillation", J Cardiol (2014)[DOI]
  4. Jeong YW, "CHA2DS2-VASc scoring system as an initial method for screening highrisk patients in acute myocardial infarction", Int J Cardiol, 174, pp.777~780 (2014)
  5. Cho JY, "Impact of high admission blood pressure without history of hypertension on clinical outcomes of patients with acute myocardial infarction: from Korea Acute Myocardial Infarction Registry", Int J Cardiol, 172, pp.e54~e58 (2014)
  6. 강동구, "Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction", Journal of Korean Medical Science, 24(5), pp.800~806 (2009), 대한의학회
  7. Li YJ, "Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: lessons from the Korea Acute Myocardial Infarction Registry", Clin Exp Pharmacol Physiol, 37, pp.581~586 (2010)
  8. 김중기, "Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the Korea Acute Myocardial Infarction Registry", The Korean Journal of Internal Medicine, 28(5), pp.547~556 (2013), 대한내과학회[DOI]
  9. Kang SH, "Cigarette smoking is paradoxically associated with low mortality risk after acute myocardial infarction", Nicotine Tob Res, 15, pp.1230~1238 (2013)
  10. Chen KY, "‘Smoker’s paradox’ in young patients with acute myocardial infarction", Clin Exp Pharmacol Physiol, 39, pp.630~635 (2012)
  11. Kang WY, "Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction", J Cardiol, 55, pp.84~91 (2010)
  12. Lee SH, "Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry)", Am J Cardiol, 102, pp.957~965 (2008)
  13. Park HW, "Early- and lateterm clinical outcome and their predictors in patients with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction", Int J Cardiol, 169, pp.254~261 (2013)
  14. Song YB, "Comparison of angiographic and other findings and mortality in non-STsegment elevation versus ST-segment elevation myocardial infarction in patients undergoing early invasive intervention", Am J Cardiol, 106, pp.1397~1403 (2010)
  15. Kim SS, "Impact of patients’arrival time on the care and in-hospital mortality in patients with non-ST-elevation myocardial infarction", Am J Cardiol, 113, pp.262~269 (2014)
  16. Park HE, "Periodic variation and its effect on management and prognosis of Korean patients with acute myocardial infarction", Circ J, 74, pp.970~976 (2010)
  17. 송영빈, "The Impact of Initial Treatment Delay Using Primary Angioplasty on Mortality among Patients with Acute Myocardial Infarction: from the Korea Acute Myocardial Infarction Registry", Journal of Korean Medical Science, 23(3), pp.357~364 (2008), 대한의학회
  18. Lee JH, "Influence of weather on daily hospital admissions for acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry)", Int J Cardiol, 144, pp.16~21 (2010)
  19. Cho JY, "Comparison of outcomes of patients with painless versus painful ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention", Am J Cardiol, 109, pp.337~343 (2012)
  20. Choi JS, "Renal dysfunction as a risk factor for painless myocardial infarction: results from Korea Acute Myocardial Infarction Registry", Clin Res Cardiol, 101, pp.795~803 (2012)
  21. Kwon TG, "N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention", Int J Cardiol, 133, pp.173~178 (2009)
  22. Kim CS, "Inf luence of renal dysfunction on clinical outcomes in patients with congestive heart failure complicating acute myocardial infarction", Int Heart J, 54, pp.304~310 (2013)
  23. 강용운, "Concomitant Impact of High-Sensitivity C-Reactive Protein and Renal Dysfunction in Patients with Acute Myocardial Infarction", Yonsei Medical Journal, 55(1), pp.132~140 (2014), 연세대학교의과대학
  24. Lee SH, "Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry", Circ J, 72, pp.1410~1418 (2008)
  25. Seo SM, "Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention", Coron Artery Dis, 23, pp.307~314 (2012)
  26. Sim DS, "Clinical outcome of unprotected left main coronary artery disease in patients with acute myocardial infarction", Int Heart J, 54, pp.185~191 (2013)
  27. Kim U, "Outcomes according to presentation with versus without cardiogenic shock in patients with left main coronary artery stenosis and acute myocardial infarction", Am J Cardiol, 110, pp.36~39 (2012)
  28. Baek JY, "Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction", Catheter Cardiovasc Interv, 83, pp.E243~E250 (2014)
  29. Kim MC, "Impact of total occlusion of an infarct-related artery on long-term mortality in acute non-ST-elevation myocardial infarction patients who underwent early percutaneous coronary intervention", Int Heart J, 53, pp.160~164 (2012)
  30. Kim SS, "Clinical outcomes of acute myocardial infarction with occluded left circumflex artery", J Cardiol, 57, pp.290~296 (2011)
  31. Kang WY, "Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe?", Int J Cardiol, 146, pp.207~212 (2011)
  32. Jeong HC, "Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention", Circ J, 72, pp.1403~1409 (2008)
  33. Choo EH, "Benefit of beta-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention", Heart, 100, pp.492~499 (2014)
  34. Jeong HC, "Comparative assessment of angiotensin II type 1 receptor blockers in the treatment of acute myocardial infarction: surmountable vs. insurmountable antagonist", Int J Cardiol, 170, pp.291~297 (2014)
  35. Jeong HC, "Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function", Int J Cardiol, 157, pp.408~411 (2012)
  36. Kim JS, "Effects of trimetazidine in patients with acute myocardial infarction: data from the Korean Acute Myocardial Infarction Registry", Clin Res Cardiol, 102, pp.915~922 (2013)
  37. Yang MJ, "Effect of nicorandil on clinical outcomes in patients with ST-segment elevation and non-ST-segment elevation myocardial infarction:based on the Korea Acute Myocardial Infarction Registry (KAMIR)", Int J Cardiol, 168, pp.4868~4869 (2013)
  38. Kim JY, "Impact of Clopidogrel loading dose in patients with chronic kidney disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction", Am J Cardiol, 110, pp.1598~1606 (2012)
  39. Choi CU, "Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: insights from the Korea Acute Myocardial Infarction Registry", Am Heart J, 161, pp.373.e1-3~382.e1-3 (2011)
  40. 조정선, "Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb", IIIa Inhibitor, 2010, pp.25(11), 1601~1608[DOI]
  41. Li YJ, "Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents", Am Heart J, 159, pp.684.e1~690.e1 (2010)
  42. Li YJ, "Low molecular weight heparin versus unfractionated heparin in patients with acute non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stents", J Cardiol, 59, pp.22~29 (2012)
  43. Sim DS, "Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction", Am J Cardiol, 103, pp.1333~1338 (2009)
  44. Sim DS, "Benefit of percutaneous coronary intervention in early latecomers with acute ST-segment elevation myocardial infarction", Am J Cardiol, 110, pp.1275~1281 (2012)
  45. Kim MC, "What is optimal revascularization strategy in patients with multivessel coronary artery disease in non-ST-elevation myocardial infarction? Multivessel or culprit-only revascularization", Int J Cardiol, 153, pp.148~153 (2011)
  46. Lee HW, "Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: analysis from Korea Acute Myocardial Infarction Registry", Cardiol J, 19, pp.256~266 (2012)
  47. Hong YJ, "The efficacy and safety of drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction (KAMIR)", Int J Cardiol, 163, pp.1~4 (2013)
  48. 심두선, "Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction", Journal of Korean Medical Science, 26(4), pp.521~527 (2011), 대한의학회
  49. Bae EH, "Drug-eluting vs. bare-metal stents for treatment of acute myocardial infarction with renal insuff iciency: results from Korea Acute Myocardial Infarction Registry", Circ J, 75, pp.2798~2804 (2011)
  50. Lee SR, "Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry", Circ J, 72, pp.392~398 (2008)
  51. Cho Y, "Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment ele vation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation", JACC Cardiovasc Interv, 3, pp.498~506 (2010)
  52. Kim HK, "Comparison of outcomes between Zotarolimus- and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction", Am J Cardiol, 105, pp.813~818 (2010)
  53. Lee MG, "Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome", Circ J, 75, pp.2120~2127 (2011)
  54. Chen KY, "Unrestricted use of 2 new-generation drug-eluting stents in patients with acute myocardial infarction: a propensity scorematched analysis", JACC Cardiovasc Interv, 5, pp.936~945 (2012)
  55. Cho SC, "Clinical outcomes of everolimus- and zotarolimus-eluting stents in patients with acute myocardial infarction for small coronary artery disease", J Cardiol, 63, pp.409~417 (2014)
  56. Ahmed K, "Role of intravascular ultrasound in patients with acute myocardial infarction undergoing percutaneous coronary intervention", Am J Cardiol, 108, pp.8~14 (2011)
  57. Hachinohe D, "Clinical impact of thrombus aspiration during primary percutaneous coronary intervention: results from Korea Acute Myocardial Infarction Registry", J Cardiol, 59, pp.249~257 (2012)
  58. Lee JH, "Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value", Am Heart J, 159, pp.1012~1019 (2010)
  59. Lee JH, "Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry)", Am J Cardiol, 104, pp.182~189 (2009)
  60. Lee CH, "Impact of statin usage patterns on outcomes after percutaneous coronary intervention in acute myocardial infarction: Korea Working Group on Myocardial Infarction registry (KorMI)study", J Geriatr Cardiol, 11, pp.93~99 (2014)
  61. Cho KH, "Low-density lipoprotein cholesterol level in patients with acute myocardial infarction having percutaneous coronary intervention (the cholesterol paradox)", Am J Cardiol, 106, pp.1061~1068 (2010)
  62. Lee KH, "Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol", J Am Coll Cardiol, 58, pp.1664~1671 (2011)
  63. Jeong HC, "Statin therapy to reduce stent thrombosis in acute myocardial infarction patients with elevated high-sensitivity C-reactive protein", Int J Cardiol, 167, pp.1848~1853 (2013)
  64. Lim SY, "Effect on short- and long-term major adverse cardiac events of statin treatment in patients with acute myocardial infarction and renal dysfunction", Am J Cardiol, 109, pp.1425~1430 (2012)
  65. Chen KY, "Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention", Circulation, 119, pp.3207~3214 (2009)
  66. Choo EH, "The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality", Coron Artery Dis, 25, pp.392~398 (2014)
  67. Lee KH, "Comparison of triple anti-platelet therapy and dual anti-platelet therapy in patients with acute myocardial infarction who had no-reflow phenomenon during percutaneous coronary intervention", Circ J, 77, pp.2973~2981 (2013)
  68. Korea Acute Myocardial Infarction Registry (KAMIR)Investigators, "Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry", Int J Cardiol, 130, pp.227~234 (2008)
  69. Park JS, "Gender differences in clinical features and in-hospital outcomes in ST-segment elevation acute myocardial infarction: from the Korean Acute Myocardial Infarction Registry (KAMIR)study", Clin Cardiol, 33, pp.E1~E6 (2010)
  70. Woo JS, "Impact of gender differences on long-term outcomes after successful percutaneous coronary intervention in patients with acute myocardial infarction", Int J Cardiol, 145, pp.516~518 (2010)
  71. Kang SH, "Sex differences in management and mortality of patients with ST-elevation myocardial infarction (from the Korean Acute Myocardial Infarction National Registry)", Am J Cardiol, 109, pp.787~793 (2012)
  72. 김학령, "Differential Prognostic Impacts of Diabetes over Time Course after Acute Myocardial Infarction", Journal of Korean Medical Science, 28(12), pp.1749~1755 (2013), 대한의학회
  73. 박근호, "Different Impact of Diabetes Mellitus on In-hospital and 1-Year Mortality in Patients with Acute Myocardial Infarction Who Underwent Successful Percutaneous Coronary Intervention: Results from the Korean Acute Myocardial Infarction Registry", The Korean Journal of Internal Medicine, 27(2), pp.180~188 (2012), 대한내과학회[DOI]
  74. Yang JH, "Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock", Crit Care, 17, pp.R218~ (2013)
  75. Lee SA, "Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients", Diabetes Care, 37, pp.2366~2373 (2014)
  76. 이민구, "Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction", Journal of Korean Medical Science, 25(10), pp.1456~1461 (2010), 대한의학회
  77. Lee MG, "Additive impact of diabetes mellitus on patients with metabolic syndrome and acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention", Int J Cardiol, 157, pp.283~285 (2012)
  78. Kim CS, "Association of metabolic syndrome and renal insufficiency with clinical outcome in acute myocardial infarction", Metabolism, 62, pp.669~676 (2013)
  79. Ahmed K, "Percutaneous coronary intervention with drug-eluting stent implantation vs. coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction", Circ J, 76, pp.721~728 (2012)
  80. Bae EH, "GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry", Am J Kidney Dis, 59, pp.795~802 (2012)
  81. Choi JS, "Predicting outcomes after myocardial infarction by using the Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease study equation: results from the Korea Acute Myocardial Infarction Registry", Nephrol Dial Transplant, 27, pp.3868~3874 (2012)
  82. Choi JS, "Association of age and CKD with prognosis of myocardial infarction", Clin J Am Soc Nephrol, 8, pp.939~944 (2013)
  83. Choi JS, "Suboptimal medical care of patients with ST-elevation myocardial infarction and renal insuff iciency: results from the Korea Acute Myocardial Infarction Registry", BMC Nephrol, 13, pp.110~ (2012)
  84. Hachinohe D, "Management of non-ST-segment elevation acute myocardial infarction in patients with chronic kidney disease (from the Korea Acute Myocardial Infarction Registry)", Am J Cardiol, 108, pp.206~213 (2011)
  85. 임상엽, "Percutaneous Coronary Intervention for Acute Myocardial Infarction in Elderly Patients with Renal Dysfunction: Results from the Korea Acute Myocardial Infarction Registry", Journal of Korean Medical Science, 28(7), pp.1027~1033 (2013), 대한의학회
  86. Piao ZH, "Clinical impact of early intervention in octogenarians with non-ST-elevation myocardial infarction", Int J Cardiol, 172, pp.462~464 (2014)
  87. 이기홍, "Characteristics, In-Hospital and Long-Term Clinical Outcomes of Nonagenarian Compared with Octogenarian Acute Myocardial Infarction Patients", Journal of Korean Medical Science, 29(4), pp.527~535 (2014), 대한의학회
  88. Yamanaka F, "Comparison of clinical outcomes between octogenarians and non-octogenarians with acute myocardial infarction in the drug-eluting stent era: analysis of the Korean Acute Myocardial Infarction Registry", J Cardiol, 62, pp.210~216 (2013)
  89. Yoo YP, "One-year clinical outcomes in invasive treatment strategies for acute ST-elevation myocardial infarction complicated by cardiogenic shock in elderly patients", J Geriatr Cardiol, 10, pp.235~241 (2013)

관련 논문AI추천

Current status of acute myocardial infarction in Korea김영조, 김용철, 김종진, 안영근, 정명호, 조명찬대한내과학회 · The Korean Journal of Internal Medicine2019 · 제34권 제1호Clinical Benefit of Statins in Korean Patients with Acute Myocardial Infarction: Experience of the Korea Acute Myocardial Infarction Registry정명호, 조경훈한국지질동맥경화학회 · 지질·동맥경화학회지2020 · 제9권 제3호Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol권현철, 김두일, 김종진, 김효수, 나승운, 박종선, 성인환, 승기배, 심두선, 안태훈, 오석규, 윤정한, 정명호, 조명찬, 주승재, 차광수, 채성철, 채제건, 최동주, 허승호, 황진용한국지질동맥경화학회 · 지질·동맥경화학회지2019 · 제8권 제2호Long-Term Clinical Outcomes according to Initial Management and Thrombolysis In Myocardial Infarction Risk Score in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction김영조, 김종진, 나승운, 류재영, 배장호, 성인환, 승기배, 안영근, 윤정한, 장양수, 정명호, 정욱성, 정해창, 조명찬, 조정관, 채성철, 채인호, 채제건, 최동훈, 허승호, 홍택종, Other Korea Acute Myocardial Infarction Registry Investigators연세대학교의과대학 · Yonsei Medical Journal2010 · 제51권 제1호The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction윤정한, Chong Jin Kim, Dong-Joo Choi, Doo Il Kim, Hyeon-Cheol Gwon, Hyo-Soo Kim, Hyun Kuk Kim, Hyun Yi Kook, In-Whan Seong, Jei Keon Chae, Jin-Yong Hwang, Jong Seon Park, Keun-Ho Park, Ki-Bae Seung, Kwang Soo Cha, Myeong Chan Cho, Myung Ho Jeong, Seok Kyu Oh, Seung-Ho Hur, Seung-Jae Joo, Seung Woon Rha, Shung Chull Chae, Sung Soo Kim, Tae Hoon Ahn, Young-Jae Ki, Youngkeun Ahn대한내과학회 · The Korean Journal of Internal Medicine2022 · 제37권 제2호관상동맥 약물 용출 스텐트 삽입 후 항혈소판제제 3제요법과 2제요법의 임상적 효과 비교김정태, 예경남, 이숙향한국임상약학회 · 한국임상약학회지2012 · 제22권 제2호

이 간행물의 다른 논문 (11건)

Role of modern 3D echocardiography in valvular heart diseaseTakahiro Shiotapp. 685-702Recent advances in treatment of aplastic anemia이성은, 이종욱, 신승환pp. 713-726Appropriate candidates for statin use in heart failure서홍석pp. 730-734Changes in the epidemiology and burden of community-acquired pneumonia in Korea윤형규pp. 735-737The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity김경진, 박성훈, 김유경, 강인숙pp. 746-753
원문 보기